WallStreetZenWallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACAD

Based on 17 analysts offering 12 month price targets for Acadia Pharmaceuticals Inc.
Min Forecast
$19.00+4.4%
Avg Forecast
$30.36+66.84%
Max Forecast
$39.00+114.29%

Should I buy or sell ACAD stock?

Based on 17 analysts offering ratings for Acadia Pharmaceuticals Inc.
Buy
Strong Buy
6 analysts 35.29%
Buy
6 analysts 35.29%
Hold
5 analysts 29.41%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACAD stock forecasts and price targets.

ACAD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-25
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-12
Oppenheimer
Top 2%
99
HoldMaintains$19.00+4.40%2024-03-12
Baird
Top 16%
85
BuyMaintains$31.00+70.33%2024-03-12
Bank of America
Top 29%
72
HoldMaintains$30.00+64.84%2024-03-12
Canaccord Genuity
Bottom 6%
6
Strong BuyMaintains$33.00+81.32%2024-03-12
JMP Securities
Top 27%
74
BuyMaintains$39.00+114.29%2024-03-12

1 of 2

Forecast return on equity

Is ACAD forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is ACAD forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ACAD revenue forecast

What is ACAD's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$964.3M+32.74%
Avg 2 year Forecast
$1.1B+47.03%
Avg 3 year Forecast
$1.2B+69.31%
ACAD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACAD revenue growth forecast

How is ACAD forecast to perform vs Biotechnology companies and vs the US market?
Company
18.84%
Industry
38.94%
Market
10.52%
ACAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACAD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACAD$18.20$30.36+66.84%Buy
CRNX$44.43$57.10+28.52%Strong Buy
DNLI$20.77$45.17+117.46%Strong Buy
IMCR$63.58$80.71+26.95%Buy
ARVN$41.33$59.21+43.27%Strong Buy

Acadia Pharmaceuticals Stock Forecast FAQ

Is Acadia Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 17 Wall Street analysts covering (NASDAQ: ACAD) stock is to Buy ACAD stock.

Out of 17 analysts, 6 (35.29%) are recommending ACAD as a Strong Buy, 6 (35.29%) are recommending ACAD as a Buy, 5 (29.41%) are recommending ACAD as a Hold, 0 (0%) are recommending ACAD as a Sell, and 0 (0%) are recommending ACAD as a Strong Sell.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.

What is ACAD's revenue growth forecast for 2024-2026?

(NASDAQ: ACAD) Acadia Pharmaceuticals's forecast annual revenue growth rate of 18.84% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Acadia Pharmaceuticals's revenue in 2024 is $726,437,000.On average, 9 Wall Street analysts forecast ACAD's revenue for 2024 to be $158,881,927,753, with the lowest ACAD revenue forecast at $154,707,111,726, and the highest ACAD revenue forecast at $161,663,600,571. On average, 9 Wall Street analysts forecast ACAD's revenue for 2025 to be $175,988,342,292, with the lowest ACAD revenue forecast at $163,618,120,353, and the highest ACAD revenue forecast at $192,700,293,810.

In 2026, ACAD is forecast to generate $202,657,107,280 in revenue, with the lowest revenue forecast at $173,667,535,419 and the highest revenue forecast at $258,196,973,407.

What is ACAD's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ACAD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ACAD's Price Target?

According to 17 Wall Street analysts that have issued a 1 year ACAD price target, the average ACAD price target is $30.36, with the highest ACAD stock price forecast at $39.00 and the lowest ACAD stock price forecast at $19.00.

On average, Wall Street analysts predict that Acadia Pharmaceuticals's share price could reach $30.36 by Mar 25, 2025. The average Acadia Pharmaceuticals stock price prediction forecasts a potential upside of 66.84% from the current ACAD share price of $18.20.

What is ACAD's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ACAD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.